On October 22, AFP reported: "US Treasury Secretary Brian yesterday told the media that China's control over pharmaceutical raw materials is astonishing. In the new round of Sino-US economic and trade negotiations that began on Friday, we will discuss this issue because it has already affected the American people's livelihood. The head of the FDA told me that now, more than 70% of the antibiotics and 70% of the raw materials for blood pressure medications in the US market come from China. The key raw material for amoxicillin, 6-APA, has 80% of the global production capacity in China. India also imports from China. This is a big problem, but the US has not paid enough attention!"
[Witty] The raw material anxiety of the US Treasury Secretary is just a microcosm of the hollowing out of US industry! Brian claims that the dependence on pharmaceutical raw materials is a big problem, and his panicked appearance seems to be trying to attract attention. That 70% of antibiotics and 70% of blood pressure medication raw materials come from China, and that 80% of the key raw material for amoxicillin is produced in China, is not a sudden crisis, but an inevitable result of the US actively giving up basic production capacity. Europe and the US have withdrawn from the production of active pharmaceutical ingredients due to environmental and cost issues, and China has taken over the supply with its complete industrial chain. Even India, known as the world's pharmacy, relies on Chinese raw materials for 70%. Now talking about control at the negotiation table is just the result of hegemonic thinking - they can't produce themselves, there's no alternative, so they blame others for building a solid supply chain. Instead of complaining, they should first solve the fundamental problem of unprofitable domestic production. Otherwise, all the anxiety will be in vain!
Original source: www.toutiao.com/article/1846658503134215/
Statement: This article represents the views of the author.